Newsbenzinga
Moderna Sets Another Fresh 52-Week High: What's Happening?
· Published
Article summary
Moderna shares are climbing again Tuesday, touching a new 52-week high of $208.90 on continued momentum from strong clinical trial news.
An excerpt from the original article.
Comments —
Loading comments…